Researcher Profile Statistics: Osmani, Arlinda
Geo Map
Region
#
NA - North America
36
EU - Europe
11
AS - Asia, other
10
OC - Oceania
2
AF - Africa
1
Total
60
Country
#
US - United States of America
36
MK - Macedonia
6
CN - China
5
AU - Australia
2
IR - Iran
2
BE - Belgium
1
DE - Germany
1
GB - United Kingdom
1
ID - Indonesia
1
JP - Japan
1
other - Other Country
10
Total
66
City
#
San Mateo
16
Menlo Park
7
San Ramon
5
Shanghai
3
Fairfield
2
Louisville
2
Skopje
2
Ann Arbor
1
Blue Bell
1
Boardman
1
other
26
Total
66
Most viewed items
#
ID: 30588 - Phenotypic characteristics and clinical outcome in hospitalized patients with COVID-19 and diabetes
66
Total
66
Most type viewed
#
ID: other -
0
ID: journal -
66
ID: conference -
0
ID: patent -
0
ID: book -
0
ID: dataset -
0
ID: selected -
0
Total
66
Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
Tot
2023
0 5
3 3 6 2
0 1 2 2
10 2
36
2024
1 9
0 7 2 3
1 7 0 0
0 0
30
Ever
66
Geo Map
Region | # |
---|---|
NA - North America | 36 |
EU - Europe | 11 |
AS - Asia, other | 10 |
OC - Oceania | 2 |
AF - Africa | 1 |
Total | 60 |
Country | # |
---|---|
US - United States of America | 36 |
MK - Macedonia | 6 |
CN - China | 5 |
AU - Australia | 2 |
IR - Iran | 2 |
BE - Belgium | 1 |
DE - Germany | 1 |
GB - United Kingdom | 1 |
ID - Indonesia | 1 |
JP - Japan | 1 |
other - Other Country | 10 |
Total | 66 |
City | # |
---|---|
San Mateo | 16 |
Menlo Park | 7 |
San Ramon | 5 |
Shanghai | 3 |
Fairfield | 2 |
Louisville | 2 |
Skopje | 2 |
Ann Arbor | 1 |
Blue Bell | 1 |
Boardman | 1 |
other | 26 |
Total | 66 |
Most viewed items | # |
---|---|
ID: 30588 - Phenotypic characteristics and clinical outcome in hospitalized patients with COVID-19 and diabetes | 66 |
Total | 66 |
Most type viewed | # |
---|---|
ID: other - | 0 |
ID: journal - | 66 |
ID: conference - | 0 |
ID: patent - | 0 |
ID: book - | 0 |
ID: dataset - | 0 |
ID: selected - | 0 |
Total | 66 |
Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Tot | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
2023 | 0 | 5 | 3 | 3 | 6 | 2 | 0 | 1 | 2 | 2 | 10 | 2 | 36 |
2024 | 1 | 9 | 0 | 7 | 2 | 3 | 1 | 7 | 0 | 0 | 0 | 0 | 30 |
Ever | 66 |